Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Inflection Point Acquisition II | IPXX | Nov 15, 2024 | 10.72 | -0.74 |
Inflection Point Acquisition II Unit | IPXXU | Nov 15, 2024 | 10.86 | 0.00 |
Infobird | IFBD | Nov 15, 2024 | 1.88 | -8.09 |
Informatica | INFA | Nov 15, 2024 | 24.79 | -1.86 |
Information Services Group | III | Nov 15, 2024 | 3.35 | +0.30 |
Information Technology ETF Vanguard | VGT | Nov 15, 2024 | 602.95 | -2.43 |
Infosys ADR | INFY | Nov 15, 2024 | 21.53 | -1.33 |
InfuSystems | INFU | Nov 15, 2024 | 8.66 | -3.46 |
ING Group ADR | ING | Nov 15, 2024 | 15.74 | +1.68 |
Ingersoll Rand | IR | Nov 15, 2024 | 102.43 | -0.54 |
Ingevity | NGVT | Nov 15, 2024 | 45.97 | +1.75 |
Ingles Markets A | IMKTA | Nov 15, 2024 | 70.05 | -3.58 |
Ingram Micro Holding Corp | INGM | Nov 15, 2024 | 22.75 | 0.00 |
Ingredion | INGR | Nov 15, 2024 | 140.83 | -5.60 |
Inhibikase Therapeutics | IKT | Nov 15, 2024 | 2.05 | -13.14 |
Inhibrx Biosciences | INBX | Nov 15, 2024 | 13.83 | -3.49 |
InMed Pharmaceuticals | INM | Nov 15, 2024 | 4.28 | -15.73 |
InMode | INMD | Nov 15, 2024 | 18.01 | -5.21 |
INmune Bio | INMB | Nov 15, 2024 | 4.96 | -8.92 |
Innate Pharma ADR | IPHA | Nov 15, 2024 | 1.44 | -13.51 |
Inno Holdings | INHD | Nov 15, 2024 | 4.63 | -2.53 |
Innodata | INOD | Nov 15, 2024 | 36.75 | -6.15 |
Innospec | IOSP | Nov 15, 2024 | 119.03 | -2.31 |
InnovAge | INNV | Nov 15, 2024 | 5.26 | -0.75 |
Innovate | VATE | Nov 15, 2024 | 4.00 | -4.99 |
Innovation Beverage Group | IBG | Nov 15, 2024 | 1.05 | 0.00 |
Innovative Eyewear | LUCY | Nov 15, 2024 | 6.85 | +3.63 |
Innovative Industrial Properties | IIPR | Nov 15, 2024 | 102.23 | -1.20 |
Innovative Industrial Properties A Pref | IIPR-A | Nov 15, 2024 | 26.39 | -0.11 |
Innovative Solutions and Support | ISSC | Nov 15, 2024 | 7.50 | -1.32 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.